Augmedix

Ambient medical documentation for health systems, hospitals and clinics

Other Enterprise
Researched · Published
RECATOOLS Score
6.9 / 10
Capability
7.5
Value for money
6
Ease of use
7
ASEAN readiness
4
API quality
Founded
HQ
Users
Launched
Developer

Overview

Augmedix is an ambient AI medical documentation platform that converts natural clinician-patient conversations into structured EHR notes in real time. One of the earliest entrants to ambient clinical documentation, it is now a wholly owned subsidiary of Commure and serves health systems, hospitals and clinics. The platform targets reduced documentation burden and improved clinician-patient interaction.

Advertisement
Advertisement

ASEAN Perspective

Augmedix in Southeast Asia

ASEAN-region availability and pricing notes coming soon. Drop the editorial team a note via /contact/ if you can supply local context (Singapore/Malaysia/Indonesia/Thailand/Vietnam).

RECATOOLS Verdict

Augmedix is a pioneer of ambient clinical documentation and remains an established, enterprise-grade option now operating inside Commure alongside Athelas. Its long track record with health systems gives it credibility against newer scribes like Abridge and Ambience.

It is sold to institutions rather than individual clinicians, with sales-gated pricing and no public API. ASEAN readiness is low given its US health-system orientation.

Independent AI-assisted assessment by RECATOOLS.

About this listing

Researched on
Published on

This entry was compiled from publicly available data including Augmedix's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Augmedix unless explicitly stated.

Data accuracy

Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.

For the latest details, please refer to Augmedix directly →

Spotted something out of date? Suggest an update →

Advertisement